The Role of Combination Therapies in Optimizing Diabetes Management
DOI:
https://doi.org/10.70749/ijbr.v2i02.244Keywords:
Type 2 Diabetes, Combination Therapy, Glycemic Control, Adherence, PakistanAbstract
Objective: To evaluate the efficacy of combination therapies in optimizing diabetes management among patients with type 2 diabetes (T2D) in Pakistan, focusing on glycemic control and treatment adherence. Methodology: A prospective, observational study was conducted at the Department of Medicine, Jinnah Hospital, Lahore from March 2023 to March 2024. A total of 250 patients were randomly assigned to either the intervention group (combination therapy) or the control group (standard therapy). Glycaemic control was assessed using HbA1c levels, while adherence was measured using the Diabetes Self-Management Questionnaire (DSMQ). Statistical analyses, including t-tests, were performed with a significance level set at (p < 0.05). Results: The intervention group showed significantly lower HbA1c levels (mean ± SD: 6.7 ± 1.0%) compared to the control group (8.1 ± 0.9%; \ (p < 0.0001\)). Adherence scores were higher in the intervention group (87 ± 8%) than in the control group (72 ± 10%; \ (p < 0.0001\)). The intervention group also had better weight control (72.5 ± 10.2 kg vs. 78.3 ± 12.1 kg; \(p < 0.05\)) and maintained better blood pressure profiles. These findings demonstrate the superior efficacy of combination therapies in achieving improved glycemic outcomes and adherence. Conclusion: Combination therapies offer significant advantages in managing T2D in Pakistan, improving glycemic control and adherence. The study underscores the need for broader adoption of combination therapies and further research on their cost-effectiveness and long-term outcomes.
References
Matthews, D., Del Prato, S., Mohan, V., Mathieu, C., Vencio, S., Chan, J. C. N., Stumvoll, M., & Paldánius, P. M. (2020). Insights from VERIFY: Early Combination Therapy Provides Better Glycaemic Durability Than a Stepwise Approach in Newly Diagnosed Type 2 Diabetes. Diabetes Therapy, 11(11), 2465–2476. https://doi.org/10.1007/s13300-020-00926-7
Yoo, S.-J., Chang, S.-A., Sohn, T. S., Kwon, H.-S., Lee, J. M., Moon, S., Proot, P., Paldánius, P. M., & Yoon, K. H. (2020). Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus. Diabetes & Metabolism Journal. https://doi.org/10.4093/dmj.2020.0173
Kim, J. Y., & Kim, N. H. (2023). Initial Combination Therapy in Type 2 Diabetes. Endocrinology and Metabolism, 39(1), 23–32. https://doi.org/10.3803/EnM.2023.1816
Nawaz, M. S., Rafique, H. S., Malik, T., Wahab, M. U., Chughtai, A. U. H., Nawaz, M. S., & Butt, M. D. (2023). CURRENT TRENDS AND AVAILABILITY OF INJECTABLE THERAPY IN PAKISTAN FOR MANAGEMENT OF DIABETES MELLITUS. International Journal of Pharmacy & Integrated Health Sciences, 4(1). https://doi.org/10.56536/ijpihs.v4i1.63
Baig, M. U., & Farooq, A. (2023). Awareness of Use of GLP-1 agonists in the treatment of Diabetes Mellitus in Pakistan. Journal of the Pakistan Medical Association, 73(8), 1769–1769. https://doi.org/10.47391/jpma.8210
Ansari, R. M., Harris, M., Hosseinzadeh, H., & Zwar, N. (2021). Healthcare Professionals’ Perspectives of Patients’ Experiences of the Self-Management of Type 2 Diabetes in the Rural Areas of Pakistan: A Qualitative Analysis. International Journal of Environmental Research and Public Health, 18(18), 9869. https://doi.org/10.3390/ijerph18189869
Javaid, Z., Imtiaz, U., Khalid, I., Saeed, H., Khan, R. Q., Islam, M., Saleem, Z., Sohail, M. F., Danish, Z., Batool, F., & Anwer, N. (2019). A randomized control trial of primary care-based management of type 2 diabetes by a pharmacist in Pakistan. BMC Health Services Research, 19(1). https://doi.org/10.1186/s12913-019-4274-z
Malik, M., Hussain, A., Aslam, U., Hashmi, A., Vaismoradi, M., Hayat, K., & Jamshed, S. (2022). Effectiveness of Community Pharmacy Diabetes and Hypertension Care Program: An Unexplored Opportunity for Community Pharmacists in Pakistan. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.710617
Majeed, Y., Shaukat, M. B., Abbasi, K. Y., & Ahmad, M. A. (2021). Indigenous plants of Pakistan for the treatment of diabetes: A review. Agrobiological Records, 4, 44-63. https://doi.org/10.47278/journal.abr/2020.028
Waseem, H., Bangash, A., & Aamir, A. (2023). From control to remission: Empowering change in type 2 diabetes care. Journal of Pakistan Medical Association, 73(12), 2538–2538. https://doi.org/10.47391/jpma.10076
Hassani, S. S., Fallahi, A., Esmaeili, S. S., & Fesharaki, M. G. (2019). The Effect of Combined Therapy with Fenugreek and Nutrition Training Based on Iranian Traditional Medicine on FBS, HgA1c, BMI, and Waist Circumference in Type 2 Diabetic Patients: a Randomized Double Blinded Clinical Trial. Journal of Advances in Medical and Biomedical Research, 27(120), 37–42. https://doi.org/10.30699/jambs.27.120.37
Jamali, A., Ram, N., Karim, S., Sattar, S., Rashid, M. S., & Islam, N. (2023). Prescribing patterns of antidiabetic drugs and glycaemic control in type 2 diabetes patients visiting tertiary care hospital based in Karachi, Pakistan. International Journal of Community Medicine and Public Health, 10(11), 4082–4088. https://doi.org/10.18203/2394-6040.ijcmph20233433
Bukhsh, A., Khan, T. M., Sarfraz Nawaz, M., Sajjad Ahmed, H., Chan, K. G., & Goh, B. H. (2019). Association of diabetes knowledge with glycemic control and self-care practices among Pakistani people with type 2 diabetes mellitus. Diabetes, Metabolic Syndrome and Obesity, 12, 1409–1417. https://doi.org/10.2147/DMSO.S209711
Weinberg Sibony, R., Segev, O., Dor, S., & Raz, I. (2023). Drug Therapies for Diabetes. International Journal of Molecular Sciences, 24(24), 17147. https://doi.org/10.3390/ijms242417147
Martinez, A., & Goldman, J. D. (2022). Efficacy and Durability of Combination Treatment With Glucagon-Like Peptide-1 Receptor Agonists and Basal Insulin. ADCES in Practice, 10(6), 42–45. https://doi.org/10.1177/2633559x221127992
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.